Stem Cell Therapy International, Inc. Announces Merger With Histostem and Launching of AmStem International, Inc.
TAMPA, FL–(Marketwire – September 25, 2009) – Stem Cell Therapy International, Inc. ( OTCBB : SCII ) is proud to announce the execution of the Reorganization and Stock Purchase Agreement (”the Agreement”) with Histostem Co., Ltd., a Korean company (”Histostem” and together with SCII, “the parties”). This results in one of the first fully merged Pacific Rim stem cell companies and cord blood …
[Read the full article here]Related News:
Stem Cell Therapy International, Inc. Announces Merger With Histostem …
Stem Cell Therapy Merges with Histostem, Launches AmStem …
Stem Cell Therapy International merges with Histostem